| Patent Number | Title | Applicant | Opposition Date |
|---|---|---|---|
| EP3626270 | New Use | NOVARTIS AG | Jul 10, 2024 |
| EP3384049 | Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-Vegf | REGENERON PHARMACEUTICALS, INC. | Apr 24, 2024 |
| EP3450562 | Method For Producing 2'-Fucosyllactose By Using Corynebacterium Glutamicum | ADVANCED PROTEIN TECHNOLOGIES CORP. | Apr 16, 2024 |
| EP3110449 | Medical Use Of A Dpp-4 Inhibitor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | Mar 26, 2024 |
Feel free to send us a message here and we will get back to you